An ELISA for the detection of TIMP-1 based on recombinant single chain Fv fusion proteins

Clinica Chimica Acta

Volumn 335, Issue 1-2, 2003, Pages 49-57

  Wozniak, Gordana ^a,b   Obermayr, Eva ^a   Jeras, Matjaz ^b   Knezevic, Mio ^b,c   Rüker, Florian ^a  

^a UNIVERSITY OF AGRICULTURAL SCIENCES   (Austria)

^b BLOOD TRANSFUSION CENTRE OF SLOVENIA   (Slovenia)

^c Educell Ltd   (Slovenia)

Author keywords

Alkaline phosphatase; ELISA; Fusion protein; Phage display; Single chain Fv; TIMP 1

Indexed keywords

SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC ANALYSIS; HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

BACTERIA (MICROORGANISMS);

EID: 0242285710     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(03)00281-X     Document Type: Article

References (32)

1. Matrisian L.M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6:1990;121-125.
2. Murphy G., Willenbrock F. Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol. 248:1995;496-510.
3. Liotta L.A., Tryggvason K., Garbisa S., Hart I., Foltz C.M., Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 284:1980;67-68.
4. Nakajima M., Welch D.R., Belloni P.N., Nicolson G.L. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res. 47:1987;4869-4876.
5. Murphy G., Reynolds J.J., Hembry R.M. Metalloproteinases and cancer invasion and metastasis. Int. J. Cancer. 44:1989;757-760.
6. Stetler-Stevenson W.G., Liotta L.A., Kleiner D.E. Jr. Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J. 7:1993;1434-1441.
7. Chambers A.F., Matrisian L.M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst. 89:1997;1260-1270.
8. Canete Soler R., Gui Y.H., Linask K.K., Muschel R.J. MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization. Brain Res. Dev. Brain Res. 88:1995;37-52.
9. Vu T.H., Shipley J.M., Bergers G., Berger J.E., Helms J.A., Hanahan D.et al. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 93:1998;411-422.
10. Halaka A.N., Bunning R.A., Bird C.C., Gibson M., Reynolds J.J. Production of collagenase and inhibitor (TIMP) by intracranial tumors and dura in vitro. J. Neurosurg. 59:1983;461-466.
11. Hicks N.J., Ward R.V., Reynolds J.J. A fibrosarcoma model derived from mouse embryo cells: growth properties and secretion of collagenase and metalloproteinase inhibitor (TIMP) by tumour cell lines. Int. J. Cancer. 33:1984;835-844.
12. Sakata K., Shigemasa K., Nagai N., Ohama K. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary. Int. J. Oncol. 17:2000;673-681.
13. Airola K., Karonen T., Vaalamo M., Lehti K., Lohi J., Kariniemi A.L.et al. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br. J. Cancer. 80:1999;733-743.
14. Baker T., Tickle S., Wasan H., Docherty A., Isenberg D., Waxman J. Serum metalloproteinases and their inhibitors: markers for malignant potential. Br. J. Cancer. 70:1994;506-512.
15. Holten-Andersen M.N., Murphy G., Nielsen H.J., Pedersen A.N., Christensen I.J., Hoyer-Hansen G.et al. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br. J. Cancer. 80:1999;495-503.
16. Kodama S., Iwata K., Iwata H., Yamashita K., Hayakawa T. Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma. J. Immunol. Methods. 127:1990;103-108.
17. Cooksley S., Hipkiss J.B., Tickle S.P., Holmes-Ievers E., Docherty A.J., Murphy G.et al. Immunoassays for the detection of human collagenase, stromelysin, tissue inhibitor of metalloproteinases (TIMP) and enzyme-inhibitor complexes. Matrix. 10:1990;285-291.
18. Clark I.M., Powell L.K., Wright J.K., Cawston T.E. Polyclonal and monoclonal antibodies against human tissue inhibitor of metalloproteinases (TIMP) and the design of an enzyme-linked immunosorbent assay to measure TIMP. Matrix. 11:1991;76-85.
19. Plumpton T.A., Clark I.M., Plumpton C., Calvin J., Cawston T.E. Development of an enzyme-linked immunosorbent assay to measure total TIMP-1 (free TIMP-1 and TIMP-1 in combination with matrix-metalloproteinases) and measurement of TIMP 1 and CRP in serum. Clin. Chim. Acta. 240:1995;137-154.
20. Murphy G., Houbrechts A., Cockett M.I., Williamson R.A., O'Shea M., Docherty A.J. The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry. 30:1991;8097-8102.
21. Sheets M.D., Amersdorfer P., Finnern R., Sargent P., Lindquist E., Schier R.et al. Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. Proc. Natl. Acad. Sci. U. S. A. 95:1998;6157-6162.
22. Wozniak G., Obermayr E., Jeras M., Knezevic M., Rüker F. Expression of TIMP-1 in Pichia pastoris. Selection of an anti-TIMP-1 specific single-chain Fv antibody from a large non-immune library. Clin. Chim. Acta. 327:2003;171-179.
23. Kerschbaumer R.J., Hirschl S., Kaufmann A., Ibl M., Koenig R., Himmler G. Single-chain Fv fusion proteins suitable as coating and detecting reagents in a double antibody sandwich enzyme-linked immunosorbent assay. Anal. Biochem. 249:1997;219-227.
24. Mandecki W., Shallcross M.A., Sowadski J., Tomazic-Allen S. Mutagenesis of conserved residues within the active site of Escherichia coli alkaline phosphatase yields enzymes with increased kcat. Protein Eng. 4:1991;801-804.
25. Kipriyanov S.M., Moldenhauer G., Little M. High level production of soluble single chain antibodies in small-scale Escherichia coli cultures. J. Immunol. Methods. 200:1997;69-77.
26. Kerschbaumer R.J., Himmler G. Harper K., Ziegler A. Recombinant antibodies-application in plant sciences and plant pathology. 1998;Taylor and Francis, London.
27. Skerra A., Pfitzinger I., Pluckthun A. The functional expression of antibody Fv fragments in Escherichia coli: improved vectors and a generally applicable purification technique. Biotechnology (NY). 9:1991;273-278.
28. Kerschbaumer R.J., Hirschl S., Schwager C., Ibl M., Himmler G. pDAP2: a vector for construction of alkaline phosphatase fusion-proteins. Immunotechnology. 2:1996;145-150.
29. Evan G.I., Lewis G.K., Ramsay G., Bishop J.M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell Biol. 5:1985;3610-3616.
30. Pack P., Pluckthun A. Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli. Biochemistry. 31:1992;1579-1584.
31. Schier R., Marks J.D., Wolf E.J., Apell G., Wong C., McCartney J.E.et al. In vitro and in vivo characterization of a human anti-c-erbB-2 single-chain Fv isolated from a filamentous phage antibody library. Immunotechnology. 1:1995;73-81.
32. Engelhardt O., Grabherr R., Himmler G., Rüker F. Two-step cloning of antibody variable domains in a phage display vector. Biotechniques. 17:1994;44-46.